Reis, Edimara S.
Mastellos, Dimitrios C.
Hajishengallis, George http://orcid.org/0000-0001-7392-8852
Lambris, John D. http://orcid.org/0000-0002-9370-5776
Article History
First Online: 2 May 2019
Competing interests
: J.D.L. and G.H. are inventors on patents or patent applications that describe the use of complement inhibitors for therapeutic purposes. J.D.L. is the founder of Amyndas Pharmaceuticals, which is developing complement inhibitors (including third-generation Compstatin analogues such as AMY-101), and the inventor of the Compstatin technology licensed to Apellis Pharmaceuticals (that is, 4(1MeW)7W/POT-4/APL-1 and PEGylated derivatives). E.S.R. and D.C.M. declare no competing interests.